ELAN
$25.30+1.91 (+8.14%)
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.
Intraday
Recent News
Elanco (ELAN): Buy, Sell, or Hold Post Q4 Earnings?
Elanco’s 26.6% return over the past six months has outpaced the S&P 500 by 23.6%, and its stock price has climbed to $23.47 per share. This was partly thanks to its solid quarterly results, and the performance may have investors wondering how to approach the situation.
A Look At Elanco Animal Health’s Valuation After A Year Of Strong Returns And Recent Share Price Pullback
What Elanco Animal Health’s Recent Returns Signal Right Now Elanco Animal Health (ELAN) has caught investor attention after a sharp move in its share price over the past year, with total return around 110% and a mixed pattern in shorter time frames. The stock’s month return shows a decline of about 4%, following a roughly 12% drop over the past week and a 2% pullback in the latest session, while the past 3 months still reflect a gain near 7%. See our latest analysis for Elanco Animal...
Tenet Healthcare, Revvity, Avantor, Azenta, and Elanco Shares Plummet, What You Need To Know
A number of stocks fell in the afternoon session after the February jobs report revealed an unexpected contraction in employment, with the healthcare industry showing significant job losses.
Jim Cramer Highlights Elanco’s “Comeback Story”
Elanco Animal Health Incorporated (NYSE:ELAN) is one of the stocks Jim Cramer commented on. Cramer highlighted the stock’s terrific performance over the last 12 months, as he commented: I love a good comeback story. Right now, there’s a great one playing out in Elanco Animal Health. That’s a veterinary medicine company spun off by Eli […]
Elanco’s AHV Deal And Befrena Win Reshape Growth And Valuation Story
Elanco Animal Health (NYSE:ELAN) announced the acquisition of AHV International, a Dutch farm animal health company focused on dairy herds. The company also received USDA approval for Befrena, a monoclonal antibody injection for canine allergic and atopic dermatitis. These two developments expand Elanco's farm animal offerings and add a new differentiated therapy to its pet health portfolio. Elanco shares most recently closed at $26.84, with the stock up 19.2% year to date and 141.2% over...